Search

Xi D Chen

from Minneapolis, MN
Age ~54
Get Report
Also known as:
Xi Donald Chen, Xi I Chen, Donald Chen
Related to:
Wei Feng Chen, 35
Connected to:
Aaron C Chen, 48Agnes H Chen, 50Aharon A Chen, 67Aiai Chen, 34Aini Chen, 35Aiqing Chen, 47Amy T Chen, 61Andreas Chen, 34Anna Chen, 50Anne H Chen, 55

Xi Chen Phones & Addresses

  • Minneapolis, MN
  • Cromwell, CT
  • Alexandria, VA
  • Middletown, CT
  • New Britain, CT
  • Aldie, VA
  • Albany, NY
  • Vernon Rockville, CT
  • Willimantic, CT
  • Mansfield Center, CT
  • Storrs Mansfield, CT

Professional Records

Lawyers & Attorneys

Xi Chen Photo 1

Xi Donald Chen, Alexandria VA - Lawyer

View page
Address:
U.S. Patent & Trademark Office
600 Dulany St, Alexandria, VA 22314
(571) 270-3399 (Office)
Licenses:
New York - Currently registered 2010
Education:
University of Connecticut, School of Law
Xi Chen Photo 2

Xi Chen, Alexandria VA - Lawyer

View page
Address:
United States Patent and Trademark Offic
Randolph Buildng Au2192 40 Dulany Street, Alexandria, VA 22314
Licenses:
Connecticut - Active 2009
Xi Chen Photo 3

Xi Chen - Lawyer

View page
Address:
(365) 686-34xx (Office)
Licenses:
Illinois - Active And Authorized To Practice Law 2005
Xi Chen Photo 4

Xi Steven Chen, Columbia MD - Lawyer

View page
Address:
Columbia, MD
(410) 227-6728 (Office)
Licenses:
New Jersey - Active 2008
Xi Chen Photo 5

Xi Chen - Lawyer

View page
ISLN:
1001069672
Admitted:
2021
Xi Chen Photo 6

Xi Chen, Columbia MD - Lawyer

View page
Office:
6480 Dobbin Rd., Columbia, MD
ISLN:
919844979
Admitted:
2008
University:
Fudan University Law School, B.S.
Law School:
Fordham University, J.D.

Medicine Doctors

Xi Chen Photo 7

Xi Chen

View page
Specialties:
Neurology
Work:
Memorial Sloan Kettering Cancer Center
1275 York Ave, New York, NY 10065
(212) 639-2000 (phone), (646) 422-0298 (fax)
Education:
Medical School
Fujian Med Coll, Fuzhou City, Fujian, China
Graduated: 1983
Procedures:
Neurological Testing
Sleep and EEG Testing
Conditions:
Hemorrhagic stroke
Myasthenia Gravis (MG)
Peripheral Nerve Disorders
Bell's Palsy
Carpel Tunnel Syndrome
Languages:
English
Description:
Dr. Chen graduated from the Fujian Med Coll, Fuzhou City, Fujian, China in 1983. He works in New York, NY and specializes in Neurology. Dr. Chen is affiliated with Bellevue Hospital Center, Memorial Sloan Kettering Cancer Center, New York Presbyterian Hospital Columbia University Medical Center and New York Presbyterian Westchester Division.
Xi Chen Photo 8

Xi Chen

View page
Specialties:
Surgery

Resumes

Resumes

Xi Chen Photo 9

Xi Chen Fremont, CA

View page
Work:
Onda Corporation

Mar 2009 to 2000
Staff Scientist
Johnson & Johnson Medical, China

Apr 2011 to Jun 2012
Lead R&D Design Engineer
Onda Corporation
Sunnyvale, CA
Nov 2007 to Nov 2008
Engineering Consultant
System Planning Corporation
Arlington, VA
May 2006 to May 2008
Consultant
ECE Department, Cornell University
Ithaca, NY
2002 to 2006
Department of Biomedical Engineering, University of Wisconsin
Madison, WI
1999 to 2002
Nanjing University
Nanjing, CN
1996 to 1999
Education:
Cornell University
Ithaca, NY
2002 to 2006
Ph.D. in Electrical Engineering
University of Wisconsin
Madison, WI
1999 to 2001
M.S. in Biomedical Engineering
Nanjing University
Nanjing, CN
1996 to 1999
M.S. in Electrical Engineering
Nanjing University
Nanjing, CN
1992 to 1996
B.S. in Electrical Engineering
Xi Chen Photo 10

Xi Chen Washington, DC

View page
Work:
Asian MBA Association

Jan 2013 to 2000
VP
Public Company Accounting Oversight Board(PCAOB)

Oct 2012 to 2000
Research and analysis Intern
Asian MBA Association

Sep 2012 to 2000
Mentor, Mentor Program
Asian MBA Association

Jan 2012 to Jan 2013
Orientation Leader
Heng Xin Certified Public Accountants LLP

Jun 2012 to Aug 2012
Auditing and Tax Intern
Visions In Action
Washington, DC
Nov 2011 to May 2012
Finance Intern
Kogod Case Competition

2012 to 2012
Miami Nation Enterprise Student ConsultantMiami, FL
2010 to Jan 2010
Qin Huang Dao Economic and Trade Co. LTD

May 2009 to Jun 2009
Assistant Accountant
Education:
American University
Washington, DC
Aug 2011
Master of Accounting
Miami University, Farmer School of Business
Oxford, OH
Jan 2008 to Jun 2011
Bachelor of Science in Business Economics
New York University
New York, NY
May 2010 to Jun 2010
Industrial Organization
University of California at Berkeley
Berkeley, CA
Jun 2008 to Aug 2008
International Business and Computer Science
Xi Chen Photo 11

Xi Chen Flushing, NY

View page
Work:
Arlington UMC Church & Arlington UMC Temple Church
Arlington, VA
Jun 2014 to Aug 2014
Bookkeeper (part-time)
Opera Guild of Northern Virginia
Arlington, VA
Apr 2014 to Aug 2014
Accountant
George Washington University
Washington, DC
Sep 2013 to May 2014
Teaching Assistant
DC EITC Campaign
Washington, DC
Feb 2014 to Apr 2014
Certified Tax Preparer
RSM CHINA CERTIFIED PUBLIC ACCOUNTANTS

Dec 2011 to Nov 2012
Staff Auditor
Tianjin Institute of Rephotography Technology

Jun 2011 to Nov 2011
Accounting Assistant
Education:
THE GEORGE WASHINGTON UNIVERSITY, School of Business
Washington, DC
2013 to 2014
Master of Accountancy
Beijing Jiaotong University
2008 to 2012
BS in Accounting
Skills:
TaxWise (Advanced), Microsoft Excel (Proficiency), QuickBooks (Advanced)
Xi Chen Photo 12

Xi Chen Minneapolis, MN

View page
Education:
University of Minnesota
Minneapolis-Saint Paul, MN
Sep 2014
M.S. in Computer Science
Nanjing University
Sep 2010 to Jun 2014
B.S. in Software Engineering
Xi Chen Photo 13

Xi Chen San Francisco, CA

View page
Work:
American Red Cross, Fairfox

Jan 2013 to 2000
Disaster Training Intern
The Multinational Risk Department, Generali China Insurance Co., Ltd

Aug 2009 to May 2010
Assistant to the department manager
Education:
The George Washington University
Washington, DC
2013
Master of Science in Statistics
Fudan University
2005 to 2009
Bachelor of Economics in Insurance and Actuarial Science
Skills:
Computer: Microsoft Word, Excel, PowerPoint, SAS programming, R programming, STATA, SPSS, SQL, Lan-DeMets Method Program; Language: Chinese, Native; English, Full professional proficiency
Xi Chen Photo 14

Xi (Lynn) Chen Burke, VA

View page
Work:
Society for Human Resource Management

Jan 2014 to 2000
Research Analyst
Washington Metropolitan Area

Jan 2013 to 2000
Volunteer Program Assessment
George Mason University

Sep 2012 to 2000
Research Assistant - Occupational Health Psychology Lab
George Mason University

Aug 2012 to 2000
Research Assistant
C&D Management Consulting

Jun 2013 to Aug 2013
Consulting Intern
Taihe Consulting

May 2012 to Jul 2012
Engagement Survey Analyst
Center for Academic Technology, Butler University
Indianapolis, IN
Sep 2010 to May 2012
Information Commons Assistant
Organizational Psychology Lab, Butler University

Sep 2010 to May 2012
Research Assistant
Education:
George Mason University
Fairfax, VA
2012 to 2014
Master of Arts in Industrial/Organizational Psychology
Butler University
Indianapolis, IN
2008 to 2012
Bachelor of Arts in Psychology; Mathematics
Skills:
quantitative research, data analysis, SPSS, Excel, Survey research, benchmarking, customer management, business intelligence, instructional design, training
Xi Chen Photo 15

Xi Chen College Park, MD

View page
Work:
Google Analytics and Google Ad

2014 to 2000
Google analyst
Cuneiform Records
Silver Spring, MD
Jun 2014 to Aug 2014
Database Developer
Maryland Food Bank
Baltimore, MD
Mar 2014 to May 2014
Marketing Internship
Xinhuayi Printing Co., LTD
Shenzhen, CN
2012 to 2013
Assistant - Information Department
Mindray Medical International Co., LTD
Shenzhen, CN
Jun 2011 to Aug 2011
Intern - Product Line & Testing Equipment Department
26th UNIVERSIADE
Shenzhen, CN
2011 to 2011
Leader of the Medical Care team in Shenzhen Natatorium
Education:
Robert H. Smith School of Business, University of Maryland
College Park, MD
Dec 2014
Master of Business Administration in Area
Shenzhen University
Shenzhen, CN
2012
Bachelor of Engineering in Electrical Engineering
leasing center
design
Xi Chen Photo 16

Xi Chen Minneapolis, MN

View page
Work:
Singapore University of Technology and Design

May 2012 to 2000
Research Assistant
University of Minnesota
Minneapolis, MN
Sep 2008 to May 2012
Teaching Assistant, Industrial and Systems Engineering
Seagate Technology
Bloomington, MN
Jun 2011 to Aug 2011
Industrial Engineer Intern
Pentair Inc.
New Brighton, MN
May 2010 to Aug 2010
Supply Chain Intern
Schulze Diabetes Institute, University of Minnesota
Minneapolis, MN
Jan 2010 to May 2010
Research Assistant
Education:
University of Minnesota
Minneapolis-Saint Paul, MN
2008 to 2013
Ph.D. in Industrial and Systems Engineering
University of Minnesota
Minneapolis-Saint Paul, MN
2008 to 2012
M.S. in Industrial and Systems Engineering
Fudan University
2003 to 2008
B.S. in Mathematics and Applied Mathematics
Skills:
Supply Chain Management, Inventory Management, Sustainability in Supply Chain, Computer Programming, Optimization

Business Records

Name / Title
Company / Classification
Phones & Addresses
Xi Chen
Owner
China City Restaurant
Xi Chen
Owner
Potamkin Chinese Restaurant
Xi S. Chen
Principal
Hong Kong Design Inc
Xi Chen
Principal
Jcy, Inc
Xi Chen
Strategic Pricing Manager
AVAYA INC
Xi Chen
SAMURAI SUSHI & HIBACHI, INC
Xi Chen
Owner
China Wok
Xi Q. Chen
President
US Housewares, Inc

Publications

Us Patents

N-Aminoalkyldibenzothiopencarboxamide Receptor Subtype Specific Ligands

View page
US Patent:
6429312, Aug 6, 2002
Filed:
Mar 19, 2001
Appl. No.:
09/812199
Inventors:
Jun Yuan - Clinton CT
Xi Chen - New Haven CT
Assignee:
Neurogen Corporation - Branford CT
International Classification:
C07D40914
US Classification:
544295, 544363, 544364, 544375, 544376, 544333, 5462811, 546146, 546175, 546194, 546202, 546256, 549 43, 549 48
Abstract:
Disclosed are compounds of the formula: or the pharmaceutically acceptable acid addition salts thereof, wherein: R , R , R , R are the same or different and represent hydrogen, C -C alkyl, halogen, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C -C alkoxy, âO CRâ, âNHCORâ, âCORâ, âSO Râ, where Râ is C -C alkyl and wherein m is 0, 1 or 2; or R , R , R , R independently represent âCONRâRâ, or âNRâRâ where Râ and Râ independently represent hydrogen or C -C alkyl; R is hydrogen or C -C alkyl; and R represents an aminoalkyl group, which compounds are useful in the treatment of affective disorders such as schizophrenia, depression, Alzheimers disease, movement disorders such as Parkinsonism and dystonia, and other disorders which respond to dopaminergic blockade such as substance abuse and obsessive compulsive disorders. Further, compounds of this invention may be useful in treating the extrapyramidal side effects associated with the use of conventional neuroleptic agents.

Exchange-Assisted Spin Transfer Torque Switching

View page
US Patent:
8134864, Mar 13, 2012
Filed:
Aug 13, 2009
Appl. No.:
12/541111
Inventors:
Randall H. Victora - New Brighton MN, US
Xi Chen - Minneapolis MN, US
Assignee:
Regents of the University of Minnesota - St. Paul MN
International Classification:
G11C 11/00
US Classification:
365158, 365171, 365173
Abstract:
In general, the invention is directed to techniques for reducing the amount of switching current that is utilized within a magnetic storage (e. g. , MRAM) device. An example apparatus includes a fixed magnetic layer that provides a fixed direction of magnetization, an exchange-coupled magnetic multi-layer structure, and a non-magnetic layer placed between the fixed magnetic layer and the exchange-coupled magnetic multi-layer structure. The exchange-coupled magnetic multi-layer structure includes a recording layer configured to record information and an assisting layer having a lower anisotropy than the recording layer. The exchange coupling between the recording and assisting layers is operable to switch a magnetization direction of the recording layer. In some cases, the exchange-coupled magnetic multi-layer structure may further include a spacer separating the recording and assisting layers and configured to weaken an exchange coupling between the recording and assisting layers.

Heteroaryl Guanidines; Inhibitors Of Viral Replication

View page
US Patent:
20060100225, May 11, 2006
Filed:
Mar 23, 2005
Appl. No.:
11/088276
Inventors:
Xi Chen - Killingworth CT, US
Andrew Thurkauf - Ridgefield CT, US
Shirley Louise-May - Guilford CT, US
International Classification:
A61K 31/513
A61K 31/505
C07D 239/32
US Classification:
514269000, 514275000, 544320000, 544330000
Abstract:
Compounds of Formula 1, and pharmaceutically acceptable forms thereof, are provided: wherein the variables X, Y, Z, A, R, R, R, Rand Rare defined herein. Certain compounds of Formula 1 described herein which possess potent antiviral activity. Certain compounds of Formula 1 that are potent and/or selective inhibitors of Hepatitis C virus replication. Pharmaceutical compositions containing one or more compounds of Formula 1, or a salt, solvate, or acylated prodrug of such compounds, and one or more pharmaceutically acceptable carriers, excipients, or diluents are also provided. Methods of treating patients suffering from certain infectious diseases by administering to such patients an amount of a compound of Formula 1 effective to reduce signs or symptoms of the disease or disorder are disclosed. These infectious diseases include viral infections, particularly HCV infections. Methods of treating human patients suffering from an infectious disease, but also encompasses methods of treating other animals, including livestock and domesticated companion animals, suffering from an infectious disease. Methods of treatment include administering a compound of Formula 1 as a single active agent or administering a compound of Formula 1 in combination with on or more other therapeutic agent.

Certain Pyrrolo Pyridine-3-Carboxamides; A New Class Of Gaba Brain Receptor Ligands

View page
US Patent:
57636095, Jun 9, 1998
Filed:
Mar 21, 1996
Appl. No.:
8/619429
Inventors:
Jun Yuan - Clinton CT
Xi Chen - New Haven CT
Assignee:
Neurogen Corporation - Branford CT
International Classification:
C07D40914
C07D40912
US Classification:
544363
Abstract:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4 are the same or different and represent hydrogen, C. sub. 1 -C. sub. 6 alkyl, halogen, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C. sub. 1 -C. sub. 6 alkoxy, --O. sub. 2 CR', --NHCOR', --COR', --SO. sub. m R', where R' is C. sub. 1 -C. sub. 6 alkyl and wherein m is 0, 1 or 2; or R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4 independently represent --CONR'R", or --NR'R" where R' and R" independently represent hydrogen or C. sub. 1 -C. sub. 6 alkyl; R. sub. 5 is hydrogen or C. sub. 1 -C. sub. 6 alkyl; and R represents an aminoalkyl group, which compounds are useful in the treatment of affective disorders such as schizophrenia, depression, Alzheimer's disease, movement disorders such as Parkinsonism and dystonia, and other disorders which respond to dopaminergic blockade such as substance abuse and obsessive compulsive disorders. Further, compounds of this invention may be useful in treating the extrapyramidal side effects associated with the use of conventional neuroleptic agents.

N-Aminoalkyl-2-Anthracenecarboxamides; New Dopamine Receptor Subtype Specific Ligands

View page
US Patent:
57032351, Dec 30, 1997
Filed:
Mar 21, 1996
Appl. No.:
8/619351
Inventors:
Jun Yuan - Clinton CT
Xi Chen - New Haven CT
Assignee:
Neurogen Corporation - Branford CT
International Classification:
C07D40110
C07D29515
C07D21114
C07D21170
US Classification:
544363
Abstract:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5, R. sub. 6, R. sub. 7, R. sub. 8 and R. sub. 9 are the same or different and represent hydrogen, C. sub. 1 -C. sub. 6 alkyl, halogen, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C. sub. 1 -C. sub. 6 alkoxy, --O. sub. 2 CR', --NHCOR', --COR', --SO. sub. m R', where R' is C. sub. 1 -C. sub. 6 alkyl and wherein m is 0, 1 or 2; or R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5, R. sub. 6, R. sub. 7, R. sub. 8 and R. sub. 9 independently represent --CONR'R", or --NR'R" where R' and R" independently represent hydrogen or C. sub. 1 -C. sub. 6 alkyl; R. sub. 10 is hydrogen or C. sub. 1 -C. sub.

Substituted Thienocycloalkylpyrazoles: Dopamine Receptor Subtype Specific Ligands

View page
US Patent:
60342528, Mar 7, 2000
Filed:
Jun 8, 1999
Appl. No.:
9/328170
Inventors:
Xi Chen - Killingworth CT
Jan W. F. Wasley - Guilford CT
Assignee:
Neurogen Corporation - Branford CT
International Classification:
C07D49504
US Classification:
5483595
Abstract:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable salts thereof wherein wherein: R. sub. 1, R. sub. 2, and and R. sub. 4 independenlty represent hydrogen, halogen, alkyl, cyano, alkoxycarbonyl, trifluoromethoxy, SO. sub. 2 NH. sub. 2 or trifluoromethyl; R. sub. 3 represents hydrogen, halogen, alkyl, alkoxy, alkylthio, hydroxy, amino, mono- or di(C. sub. 1 -C. sub. 6)alkylamino, cyano, alkoxycarbonyl, trifluoromethoxy, SO. sub. 2 NH. sub. 2 or trifluoromethyl; or R. sub. 3 represents optionally substituted phenyl; X represents (CH. sub. 2). sub. n where n is an integer; and m is 0 or an integer, which compounds are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents.

N-Piperidinyl- And N-Tetrahydropyridinyl-2-Anthracenecarboxamides: Dopamine Receptor Subtype Specific Ligands

View page
US Patent:
58832572, Mar 16, 1999
Filed:
Dec 19, 1997
Appl. No.:
8/994588
Inventors:
Jun Yuan - Clinton CT
Xi Chen - New Haven CT
Assignee:
Neurogen Corporation - Branford CT
International Classification:
C07D40112
C07D21170
C07D21114
US Classification:
546203
Abstract:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5, R. sub. 6, R. sub. 7, R. sub. 8 and R. sub. 9 are the same or different and represent hydrogen, C. sub. 1 -C. sub. 6 alkyl, halogen, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C. sub. 1 -C. sub. 6 alkoxy, --O. sub. 2 CR', --NHCOR', --COR', --SO. sub. m R', where R' is C. sub. 1 -C. sub. 6 alkyl and wherein m is 0, 1 or 2; or R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4, R. sub. 5, R. sub. 6, R. sub. 7, R. sub. 8 and R. sub. 9 independently represent --CONR'R", or --NR'R" where R' and R" independently represent hydrogen or C. sub. 1 -C. sub. 6 alkyl; R. sub. 10 is hydrogen or C. sub. 1 -C. sub.

N-Aminoalkyldibenzothiophenecarboxamides; New Dopamine Receptor Subtype Specific Ligands

View page
US Patent:
60404590, Mar 21, 2000
Filed:
Aug 5, 1999
Appl. No.:
9/368542
Inventors:
Jun Yuan - Clinton CT
Xi Chen - New Haven CT
Assignee:
Neurogen Corporation - Branford CT
International Classification:
C07D33376
US Classification:
549 43
Abstract:
Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4 are the same or different and represent hydrogen, C. sub. 1 -C. sub. 6 alkyl, halogen, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C. sub. 1 -C. sub. 6 alkoxy, --O. sub. 2 CR', --NHCOR', --COR', --SO. sub. m R', where R' is C. sub. 1 -C. sub. 6 alkyl and wherein m is 0, 1 or 2; or R. sub. 1, R. sub. 2, R. sub. 3, R. sub. 4 independently represent --CONR'R", or --NR'R" where R' and R" independently represent hydrogen or C. sub. 1 -C. sub. 6 alkyl; R. sub. 5 is hydrogen or C. sub. 1 -C. sub. 6 alkyl; and R represents an aminoalkyl group, which compounds are useful in the treatment of affective disorders such as schizophrenia, depression, Alzheimer's disease, movement disorders such as Parkinsonism and dystonia, and other disorders which respond to dopaminergic blockade such as substance abuse and obsessive compulsive disorders. Further, compounds of this invention may be useful in treating the extrapyramidal side effects associated with the use of conventional neuroleptic agents.

Wikipedia References

Xi Chen Photo 17

Xi Chen

Control profile
Xi D Chen from Minneapolis, MN, age ~54 Get Report